Medindia
Medindia LOGIN REGISTER
Advertisement

Cadence Pharmaceuticals Announces OFIRMEV(TM) NDA Action Date of November 4, 2010

Saturday, May 15, 2010 Medico Legal News
Advertisement

Contact:

William R. LaRue

Aimee Corso

SVP & Chief Financial Officer

Media & Investor Relations

Cadence Pharmaceuticals, Inc.

WCG

Phone : 858-436-1400

Phone : 310-780-2661

Sponsored Post and Backlink Submission


Latest Press Release on Medico Legal News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close